相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TGF-β1 Signaling and Tissue Fibrosis
Kevin K. Kim et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Jessica K. Gordon et al.
ARTHRITIS & RHEUMATOLOGY (2018)
New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice
Sayam Dubash et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2018)
Review article: novel oral-targeted therapies in inflammatory bowel disease
J. R. White et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
Christopher P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review
Mathilde Thiebaut et al.
AUTOIMMUNITY REVIEWS (2018)
Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation
Keith M. Sullivan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline
Mariana G. Tarrago et al.
CELL METABOLISM (2018)
Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy
Swati Bhattacharyya et al.
IMMUNOLOGY LETTERS (2018)
Dendritic cells in systemic sclerosis: Advances from human and mice studies
Alsya J. Affandi et al.
IMMUNOLOGY LETTERS (2018)
Toll Like Receptors in systemic sclerosis: An emerging target
Steven O'Reilly
IMMUNOLOGY LETTERS (2018)
JAK-STAT signaling pathway inhibition: a role for treatment of discoid lupus erythematosus and dermatomyositis
Jared S. Kahn et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease
Hua Xiao et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Mechanosensing and fibrosis
Daniel J. Tschumperlin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis
Tetsuo Toyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs
Massimo Gadina et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
The use of JAK inhibitors in the treatment of progressive systemic sclerosis
S. C. Deverapalli et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication
Pardis Pakshir et al.
MATRIX BIOLOGY (2018)
Existing and novel biomarkers for precision medicine in systemic sclerosis
Peter J. Wermuth et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Type I interferon in rheumatic diseases
Theresa L. Wampler Muskardin et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Cannabinoids for the treatment of rheumatic diseases - where do we stand?
Daphna Katz-Talmor et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
T follicular helper-like cells contribute to skin fibrosis
Devon K. Taylor et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
Eduardo N. Chini et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Fibrotic microtissue array to predict anti-fibrosis drug efficacy
Mohammadnabi Asmani et al.
NATURE COMMUNICATIONS (2018)
Matrix Stiffness: the Conductor of Organ Fibrosis
Alba Santos et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
Treatment Algorithms for Systemic Sclerosis According to Experts
Andreu Fernandez-Codina et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study
Yannick Allanore et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary Disease
Katie Streicher et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Metformin and Autoimmunity: A New Deal of an Old Drug
Francesco Ursini et al.
FRONTIERS IN IMMUNOLOGY (2018)
BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
Takashi Matsushita et al.
SCIENCE ADVANCES (2018)
The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
Amaal E. Abdulle et al.
FRONTIERS IN PHYSIOLOGY (2018)
Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?
Cosimo Bruni et al.
FRONTIERS IN IMMUNOLOGY (2018)
New insights into the genetics and epigenetics of systemic sclerosis
Chiara Angiolilli et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Dinesh Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis
Suzanne Kafaja et al.
JCI INSIGHT (2018)
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts
Maurizio Cutolo et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status
Tamer A. Gheita et al.
CLINICAL RHEUMATOLOGY (2018)
Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients
Lucas C. M. Arruda et al.
BLOOD ADVANCES (2018)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review
Gleb Slobodin et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Sean Gaine et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Small molecule therapy for managing moderate to severe psoriatic arthritis
Luisa Costa et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
Miroslava Didiasova et al.
FASEB JOURNAL (2017)
Unfolding the pathogenesis of scleroderma through genomics and epigenomics
Pei-Suen Tsou et al.
JOURNAL OF AUTOIMMUNITY (2017)
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82
Robert Lafyatis et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Role of B cells in the pathogenesis of systemic sclerosis
S. Sanges et al.
REVUE DE MEDECINE INTERNE (2017)
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
David Lagares et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
Dimitrios Daoussis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative
Jun Wei et al.
TRANSLATIONAL RESEARCH (2017)
Frontiers of Antifibrotic Therapy in Systemic Sclerosis
Joerg H. W. Distler et al.
ARTHRITIS & RHEUMATOLOGY (2017)
CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis Data From Two Independent Cohorts
Minghua Wu et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis
Marzia Rossato et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis A Randomized, Placebo-Controlled, Phase II Study
Christopher P. Denton et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury
Tobias Puengel et al.
PLOS ONE (2017)
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Viktor Martyanov et al.
PLOS ONE (2017)
Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways
Agnieszka P. Grzegorzewska et al.
SCIENTIFIC REPORTS (2017)
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
John Varga et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis
Jingang Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
Jerome Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis
Barry S. Shea et al.
JCI INSIGHT (2017)
Mechanisms and consequences of Jak-STAT signaling in the immune system
Alejandro V. Villarino et al.
NATURE IMMUNOLOGY (2017)
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis
Zana Brkic et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis
Yang Xu et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein
Irida Kastrati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
Takashi Matsushita et al.
RHEUMATOLOGY (2016)
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis
Matthieu Ponsoye et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Cannabinoids, inflammation, and fibrosis
Robert B. Zurier et al.
FASEB JOURNAL (2016)
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Thomas A. Wynn et al.
IMMUNITY (2016)
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis DUAL-1 and DUAL-2 Randomized Clinical Trials
Dinesh Khanna et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
Reducing the risk of failure: biomarker-guided trial design
Michael J. Townsend et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Ian B. Robertson et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Kaname Akamata et al.
ONCOTARGET (2016)
Cellular Therapies in Systemic Sclerosis: Recent Progress
Femke C. C. van Rhijn-Brouwer et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis
Athanasios Mavropoulos et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Toll-like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β-Dependent Fibroblast Activation
Feng Fang et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Redox mechanisms in age-related lung fibrosis
Ashish Kurundkar et al.
REDOX BIOLOGY (2016)
Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis
Pawel Zerr et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
Elizabeth R. Volkmann et al.
ARTHRITIS RESEARCH & THERAPY (2016)
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu et al.
AGING CELL (2015)
Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts Possible Implications in Idiopathic Pulmonary Fibrosis
Varvara Kirillov et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis
Katherine G. MacDonald et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa M. Rice et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
Carmel B. Nanthakumar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis
Roberta Goncalves Marangoni et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Jessica K. Gordon et al.
ARTHRITIS RESEARCH & THERAPY (2015)
The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling
Jun Wei et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Increased Expression of NAPDH Oxidase 4 in Systemic Sclerosis Dermal Fibroblasts Regulation by Transforming Growth Factor β
Sonsoles Piera-Velazquez et al.
ARTHRITIS & RHEUMATOLOGY (2015)
A Reactive Oxygen Species-Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis
Tatiana Spadoni et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Systemic sclerosis patients present alterations in the expression of molecules involved in B-cell regulation
Lilian Soto et al.
FRONTIERS IN IMMUNOLOGY (2015)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Amelioration of Tissue Fibrosis by Toll-like Receptor 4 Knockout in Murine Models of Systemic Sclerosis
Takehiro Takahashi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Cellular Mechanisms of Tissue Fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription
Pei-Suen Tsou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Michal Tomcik et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study
J. Baraut et al.
BONE MARROW TRANSPLANTATION (2014)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis
Masataka Kuwana et al.
Modern Rheumatology (2014)
Transforming growth factor β-at the centre of systemic sclerosis
Robert Lafyatis
NATURE REVIEWS RHEUMATOLOGY (2014)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis
Lucille Desallais et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Prevalence of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis New Data From a French Cohort and a Systematic Review and Meta-Analysis
Vincent Sobanski et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Association of Interferon- and Transforming Growth Factor β-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis
Romy B. Christmann et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Homeostatic control of regulatory T cell diversity
Adrian Liston et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses A Novel Mechanism for Maintaining and Amplifying Fibrosis in Scleroderma
Swati Bhattacharyya et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial
Paul P. Tak et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis
Xiaochun Liu et al.
ARTHRITIS AND RHEUMATISM (2013)
Review: Evidence That Systemic Sclerosis Is a Vascular Disease
Marco Matucci-Cerinic et al.
ARTHRITIS AND RHEUMATISM (2013)
Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development
Flavia V. Castelino et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Recent Developments in Myofibroblast Biology Paradigms for Connective Tissue Remodeling
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
Shun Kitaba et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
Estrella Garcia Gonzalez et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Angelika Horn et al.
ARTHRITIS AND RHEUMATISM (2012)
JAK-2 as a Novel Mediator of the Profibrotic Effects of Transforming Growth Factor β in Systemic Sclerosis
Clara Dees et al.
ARTHRITIS AND RHEUMATISM (2012)
Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells
Jun Wei et al.
ARTHRITIS AND RHEUMATISM (2012)
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease
Maria De Santis et al.
CLINICAL RESPIRATORY JOURNAL (2012)
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
MicroRNA-29: a potential therapeutic target for systemic sclerosis
Wen-Jia Peng et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Swati Bhattacharyya et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
T cells in systemic sclerosis: a reappraisal
Steven O'Reilly et al.
RHEUMATOLOGY (2012)
Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study
Tatiana S. Rodriguez-Reyna et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases
P. Szodoray et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
Feng Fang et al.
ARTHRITIS RESEARCH & THERAPY (2012)
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study
M. O. Becker et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial
Robert F. Spiera et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Antiinflammatory and Antifibrotic Effects of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in a Murine Model of Interstitial Lung Disease
Galina S. Bogatkevich et al.
ARTHRITIS AND RHEUMATISM (2011)
Imatinib in Active Diffuse Cutaneous Systemic Sclerosis: Results of a Six-Month, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Pilot Study at a Single Center
Janet Pope et al.
ARTHRITIS AND RHEUMATISM (2011)
Role of IL-13 in systemic sclerosis
Patrizia Fuschiotti
CYTOKINE (2011)
Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis?
Iman H. Bassyouni et al.
JOINT BONE SPINE (2011)
Dicer Insufficiency and MicroRNA-155 Overexpression in Lupus Regulatory T Cells: An Apparent Paradox in the Setting of an Inflammatory Milieu
Anagha A. Divekar et al.
JOURNAL OF IMMUNOLOGY (2011)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt et al.
LANCET (2011)
Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease
Marie-Elise Truchetet et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity
Gleb Slobodin et al.
CELLULAR IMMUNOLOGY (2010)
Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
Fei Liu et al.
JOURNAL OF CELL BIOLOGY (2010)
A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity
Jennifer L. Sargent et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Increased Production of a Proliferation-inducing Ligand (APRIL) by Peripheral Blood Mononuclear Cells Is Associated with Antitopoisomerase I Antibody and More Severe Disease in Systemic Sclerosis
Marek Bielecki et al.
JOURNAL OF RHEUMATOLOGY (2010)
Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis
Hala Y. Sadik et al.
RHEUMATOLOGY (2010)
TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis
Glenda Trujillo et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Jane Hoyt Buckner
NATURE REVIEWS IMMUNOLOGY (2010)
ABSOLUTE, COUNT OF T AND B LYMPHOCYTE SUBSETS IS DECREASED IN SYSTEMIC SCLEROSIS
T. Gambichler et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2010)
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
Minghua Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
STAT4 Is a Genetic Risk Factor for Systemic Sclerosis Having Additive Effects With IRF5 on Disease Susceptibility and Related Pulmonary Fibrosis
P. Dieude et al.
ARTHRITIS AND RHEUMATISM (2009)
Treatment With Imatinib Prevents Fibrosis in Different Preclinical Models of Systemic Sclerosis and Induces Regression of Established Fibrosis
Alfiva Akhmetshina et al.
ARTHRITIS AND RHEUMATISM (2009)
Transforming growth factor β as a therapeutic target in systemic sclerosis
John Varga et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate
S. Bhattacharyya et al.
ONCOGENE (2009)
Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
M. T. Carulli et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Endothelial/lymphocyte activation leads to prominent CD4+T cell infiltration in the gastric mucosa of patients with systemic sclerosis
Mirko Manetti et al.
ARTHRITIS AND RHEUMATISM (2008)
Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial
Clarissa E. Vergunst et al.
ARTHRITIS AND RHEUMATISM (2008)
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis - a longitudinal study
A. Antonelli et al.
RHEUMATOLOGY (2008)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
B cell infiltration in systemic sclerosis-associated interstitial lung disease
Robert Lafyatis et al.
ARTHRITIS AND RHEUMATISM (2007)
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
Jasper J. Haringman et al.
ARTHRITIS AND RHEUMATISM (2006)
Diminished induction of skin fibrosis in mice with MCP-1 deficiency
Ahalia M. Ferreira et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Elevated serum BAFF levels in patients with systemic sclerosis - Enhanced BAFF signaling in systemic sclerosis B lymphocytes
T Matsushita et al.
ARTHRITIS AND RHEUMATISM (2006)
B lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse
N Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Altered blood B lymphocyte Homeostasis in systemic sclerosis - Expanded naive B cells and diminished but activated memory B cells
S Sato et al.
ARTHRITIS AND RHEUMATISM (2004)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
Quantitative genetic variation in CD19 expression correlates with autoimmunity
S Sato et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
